How the Healey ALS Platform Trial is Helping to Accelerate the Pathway to New ALS Treatments
Sabrina Paganoni, MD, PhD, speaks about the HEALEY ALS Platform Trial, a novel approach to testing new therapeutics for ALS patients.
Research at Massachusetts General Hospital includes multitude of hospital-wide centers, institutes and programs as well as collaborations with other institutions.
Sabrina Paganoni, MD, PhD, speaks about the HEALEY ALS Platform Trial, a novel approach to testing new therapeutics for ALS patients.
Could early-life childhood adversity such as trauma, socio-economic hardship, or parental illness have an impact mental health and resilience later in life?
In this study, investigators created a very large dataset of rare genetic variants and their association with diabetes, which can help us distinguish those variants more likely to cause monogenic diabetes vs those that are benign.
The paper describes a first-of-its-kind spatial multiomic atlas derived from nearly one million cells of the first trimester human placenta at single-cell and molecular resolution.
New study shows that being sedentary increases the risk of the most common types of heart disease, even among those who get enough exercise
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.